Diet and exercise may keep cancer patients stronger during chemo
NCT ID NCT06141785
First seen Jun 25, 2026 · Last updated Sep 01, 2026 · Updated 3 times
Summary
This study tests whether early, personalized nutritional support and a simple home exercise program can prevent weight loss and improve quality of life in 200 adults with lung, colorectal, ovarian, or pancreatic cancer starting palliative chemotherapy. Participants receive guidance from a dietitian throughout treatment. Researchers will compare their outcomes to a historical group that received standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- individualized nutritional counseling and a home-based exercise program
- What this could lead to
- If it works, this could help cancer patients maintain weight, muscle, and quality of life during palliative chemotherapy.
- What could go wrong
- This is a small, early-stage study comparing to past patients, not a randomized controlled trial. Results may not apply to all cancer types or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients who are newly diagnosed with lung, colorectal, ovarian, or pancreatic cancer. * patients treated with first-line palliative chemotherapy * patients who are able to read, write and speak Danish * patients ≥18 years of age * patients who are cognitive well-functioning Exclusion Criteria: * Significant cognitive impairment (e.g. dementia) compromising the ability to provide informed consent or participate meaningfully in the intervention * Lack of access to electronic mail * Inability to comply with the study protocol due to medical, psychosocial or practical factors
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gødstrup Hospital
Herning, 7400, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Surgeons could freeze lung tumors from miles away using 5G robots
- Four-Part check may reveal hidden malnutrition in sickest kids
- Can protein shakes help older veterans bounce back after surgery?
- Why do some malnourished infants recover and others Don't? hospitals track every gram
- Can a gentler blood thinner shield cancer patients from new clots?